HKD 0.07
(-5.71%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 810.79 Million HKD | -11.24% |
2022 | 913.43 Million CNY | -40.55% |
2021 | 1.53 Billion CNY | -9.34% |
2020 | 1.69 Billion CNY | 54.59% |
2019 | 1.09 Billion CNY | -14.03% |
2018 | 1.27 Billion CNY | -26.35% |
2017 | 1.73 Billion CNY | 2.64% |
2016 | 1.68 Billion CNY | 5.0% |
2015 | 1.6 Billion CNY | -5.08% |
2014 | 1.69 Billion CNY | 15.3% |
2013 | 1.46 Billion CNY | 16.1% |
2012 | 1.26 Billion CNY | 15.95% |
2011 | 1.09 Billion CNY | 252.36% |
2010 | 309.47 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 708.62 Million CNY | 0.0% |
2023 Q2 | 931.1 Million CNY | 0.0% |
2023 Q4 | 810.79 Million HKD | 0.0% |
2023 FY | 810.79 Million HKD | -11.24% |
2022 Q2 | 2.91 Billion CNY | 0.0% |
2022 FY | 913.43 Million CNY | -40.55% |
2022 Q4 | 913.43 Million CNY | 0.0% |
2021 Q4 | 1.25 Billion CNY | 0.0% |
2021 Q2 | 1.34 Billion CNY | 0.0% |
2021 FY | 1.53 Billion CNY | -9.34% |
2020 Q2 | 1.23 Billion CNY | 0.0% |
2020 FY | 1.69 Billion CNY | 54.59% |
2020 Q4 | 1.42 Billion CNY | 0.0% |
2019 FY | 1.09 Billion CNY | -14.03% |
2019 Q2 | 1.13 Billion CNY | 0.0% |
2019 Q4 | 1.09 Billion CNY | 0.0% |
2018 FY | 1.27 Billion CNY | -26.35% |
2018 Q2 | 1.68 Billion CNY | 0.0% |
2018 Q4 | 1.27 Billion CNY | 0.0% |
2017 Q4 | 1.73 Billion CNY | 0.0% |
2017 Q2 | 1.69 Billion CNY | 0.0% |
2017 FY | 1.73 Billion CNY | 2.64% |
2016 Q4 | 1.68 Billion CNY | 0.0% |
2016 Q2 | 1.61 Billion CNY | 0.0% |
2016 FY | 1.68 Billion CNY | 5.0% |
2015 FY | 1.6 Billion CNY | -5.08% |
2015 Q4 | 1.6 Billion CNY | 0.0% |
2015 Q2 | 1.69 Billion CNY | 0.0% |
2014 Q2 | 1.64 Billion CNY | 0.0% |
2014 FY | 1.69 Billion CNY | 15.3% |
2014 Q4 | 1.69 Billion CNY | 0.0% |
2013 Q2 | 1.34 Billion CNY | 0.0% |
2013 Q4 | 1.46 Billion CNY | 0.0% |
2013 FY | 1.46 Billion CNY | 16.1% |
2012 Q2 | 1.15 Billion CNY | 0.0% |
2012 Q4 | 1.26 Billion CNY | 0.0% |
2012 FY | 1.26 Billion CNY | 15.95% |
2011 Q4 | 1.09 Billion CNY | 0.0% |
2011 Q2 | 571.62 Million CNY | 0.0% |
2011 FY | 1.09 Billion CNY | 252.36% |
2010 FY | 309.47 Million CNY | 0.0% |
2010 Q4 | 309.47 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 882.58 Million HKD | 8.134% |
Innovative Pharmaceutical Biotech Limited | 1.38 Billion HKD | 41.375% |
China Overseas Nuoxin International Holdings Limited | 149.17 Million HKD | -443.503% |
Huasheng International Holding Limited | 1.63 Billion HKD | 50.44% |
Fourace Industries Group Holdings Limited | 475.91 Million HKD | -70.365% |
Evergreen Products Group Limited | 1.63 Billion HKD | 50.306% |
EC Healthcare | 5.37 Billion HKD | 84.91% |
Ming Fai International Holdings Limited | 1.96 Billion HKD | 58.743% |
Blue Moon Group Holdings Limited | 12.05 Billion HKD | 93.273% |
SuperRobotics Holdings Limited | 27.55 Million HKD | -2842.556% |
Takbo Group Holdings Limited | 279.77 Million HKD | -189.802% |
Hyfusin Group Holdings Limited | 686.91 Million HKD | -18.033% |